Consolidated Statement of Cash Flows

For the years ended December 31, 2019 and 2018

Notes 2019

SAR ’000
2018
Restated
SAR ’000
Operating Activities
Net income 41 (a) 239,461 575,897
Adjustments to reconcile net income to net cash provided from operating activities
Net accretion of discounts and net amortization of premiums on investments, net 36,428 46,095
Net change in accrued special commission income 193,514 (24,243)
Net change in accrued special commission expense (33,611) 85,364
Net change in deferred loan fees 27,031 (10,300)
(Gains) losses on FVOCI debt securities, net 23 (43,518) 59
Unrealized fair value through profit and loss (7,350) 20,464
Realized fair value through profit and loss (3,275) (4,528)
Depreciation and amortization 9 143,517 103,239
Loss on sales of property, equipment, and intangibles 2,629 30
Gain on sale of other real estate (33,886)
Provisions for credit and other losses 40 (a) 1,342,637 246,972
Share in earnings of associates 8 (b) (88,156) (111,195)
Share based provisions 37 (b) 5,400
1,775,421 933,254
Net (increase) decrease in operating assets:
Statutory deposit with SAMA (221,996) 114,975
Due from banks and other financial institutions maturing after three months from acquisition date (128,566) (53,578)
Loans and advances 800,384 (88,742)
Positive fair values of derivatives (60,822) (545,360)
Other real estate 228,525
Other assets (258,546) 114,278
Net increase (decrease) in operating liabilities:
Due to banks and other financial institutions 1,177,687 4,971,376
Customers’ deposits 5,385,416 (3,251,040)
Negative fair values of derivatives (203,539) 354,885
Other liabilities 221,110 115,491
8,715,074 2,665,539
Zakat and Income Tax payments (476,080) (49,840)
Net cash provided from operating activities 8,238,994 2,615,699
Investing Activities
Proceeds from sales and maturities of investments 1,939,699 1,820,969
Purchases of investments (2,857,924) (5,072,207)
Dividends received from associates 8 (b) 105,709 93,323
Investments in associates 8 (b) (1,876)
Acquisitions of property, equipment, and intangibles 9 (163,646) (118,707)
Proceeds from sales of property, equipment, and intangibles 7,705 1,236
Net cash used in investing activities (968,457) (3,277,262)
Financing Activities
Sale of shares for employee options, net 37 (b) 16,651
Dividends paid 26 (450,000)
Vesting of employee share options, net 37 (b) 36,218
Treasury shares purchased 39 (253,531) (787,536)
Proceeds from Tier I Sukuk 38 215,000 1,000,000
Redemption of Subordinated debt 15 (2,000,000)
Tier I Sukuk costs (122,024) (94,904)
Net cash used in financing activities (2,160,555) (279,571)
Net increase/(decrease) in cash and cash equivalents 5,109,982 (941,134)
Cash and cash equivalents
Cash and cash equivalents at the beginning of the year 4 (b) 4,503,172 5,444,306
Net increase/(decrease) in cash and cash equivalents 5,109,982 (941,134)
Cash and cash equivalents at the end of the year 4 (b) 9,613,154 4,503,172
Supplemental special commission information
Special commission received 4,096,002 3,609,173
Special commission paid 1,661,263 1,263,479
Supplemental non-cash information
Total other comprehensive income (loss) 522,033 (373,735)
Adoption of IFRS 9 on January 1, 2018 (822,556)
Adoption of IFRS 16 on January 1, 2019 3 (a) (ii) 246,601
Other real estate 32 (b) 121,285
Zakat settlement from 2006 to 2017, net of fair value adjustment 27 (b) 711,807

The accompanying Notes 1 to 44 form an integral part of these Consolidated Financial Statements.

Close